News
Work and Cancer — Free, Virtual Conference, June 24, 2022
Join Cancer + Careers when they present the 12th Annual National Conference on Work and Cancer on Friday, June 24, 2022. This free, virtual, day-long event is open to patients, caregivers, healthcare professionals, advocates, employers/HR and …
READ MOREAsk the NET Expert – May 2022
The Carcinoid Cancer Foundation is excited to have launched a new web-based program for the neuroendocrine tumor (NET) community – Ask the NET Expert. Each month, we are featuring a different physician who …
READ MORESNMMI Patient Education Day — Hybrid (In-Person and Virtual)
The Society of Nuclear Medicine and Molecular Imaging will offer a special Patient Education Day on Sunday, June 12 as part of its 2022 Annual Meeting. This free event offers patients and caregivers a unique opportunity to learn about the role of nuclear…
READ MORENew Appointment for NET Expert Dr. Boris Naraev
Congratulations to Dr. Boris Naraev upon being appointed Medical Oncology Leader – Gastrointestinal, Neuroendocrine, and Rare Cancers Program at the Anderson Family Cancer Institute in Jupiter, Florida. Dr. Naraev previously led the Neuroendocrine…
READ MOREThe Passing of Dr. Thomas O’Dorisio
It is with great sadness that we share the passing of Dr. Thomas O’Dorisio, a pioneer and leader in the field of neuroendocrine cancer; a compassionate and dedicated physician; an outstanding colleague at the University of Iowa; and beloved husband to…
READ MORENew NET Research Collaboration
Exciting news about a new research collaboration to discover and develop novel therapies targeting immune checkpoint proteins for the treatment of neuroendocrine tumors and other cancers. The collaboration was announced by NexImmune Inc., a clinical-stage…
READ MORESecond Generation Immunohistochemical Markers: Reflections from Clinical Implementation
This article from pathologist Carl Christofer Juhlin, MD, PhD, of Karolinska Institutet in Sweden identifies second-generation neuroendocrine immunohistochemical markers. These markers can help identify the site of primary neuroendocrine…
READ MORENew Online Survey For Carcinoid Syndrome Patients, Open Through February 12
You can make a difference in how a clinical trial is designed! Share your thoughts today by participating in a new survey for neuroendocrine cancer patients with Carcinoid Syndrome. The survey will be online through February 12. Read more here, https://t.e2ma.net/…/13668e89c4ceb31e31b3598f2f3b10f1…
READ MORELoving Lemons Even When You Wanted Oranges
In a feature article in Oncology Fellows, neuroendocrine cancer expert Robert Ramirez, DO, FACP, describes his path to clinical thoracic oncology after originally planning on entering the field of academics early in his career. Dr. Ramirez is Associate…
READ MORE2021 Monica Warner Award: Call for Nominations — Deadline January 21, 2022
Advanced Accelerator Applications (AAA), a Novartis company, has announced that nominations are open for the 12th Annual Monica Warner Award! AAA is continuing the Novartis tradition of sponsoring the award, which commemorates the life and work…
READ MORE